Prevalence of Chronic Obstructive Pulmonary Disease in Adults Aged 40 Years and Older in China From 2014 to 2024: A Systematic Review and Meta-Analysis.
IF 1.4 4区 医学Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
{"title":"Prevalence of Chronic Obstructive Pulmonary Disease in Adults Aged 40 Years and Older in China From 2014 to 2024: A Systematic Review and Meta-Analysis.","authors":"Yinxia Luo, Fang Wang, Xia Zeng, Sufang Tan, Liwen Xiang, Shuwen Pang, Xiaoxuan Guo, Xiaorong Mao","doi":"10.1177/10105395251329194","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic Obstructive Pulmonary Disease (COPD) imposed a heavy disease burden on China. The aim of this study was to identify the prevalence of COPD in adults aged 40 years and older in China through a systematic review and meta-analysis. A web-based search of 11 databases (including PubMed and Web of Science) from January 2014 to September 2024, using specified search/MeSH (Medical Subject Headings) terms and keywords, was conducted. A total of 92 studies (39 320 patients) were included. The combined prevalence of COPD in Chinese adults aged 40 years and older from 2014 to 2024 was 12.1% (11.3%-13.0%). Subgroup analysis showed that the prevalence was higher in males (16.4%, 15.2%-17.6%) than in females (8.4%, 7.5%-9.3%). The lowest prevalence was 4.8% in the age group of 40 to 49 years and 23.7% in the age group of over 70 years. The prevalence was highest in patients with a BMI of less than 18.5 kg/m<sup>2</sup> (22.4%) and decreased with increasing BMI. The prevalence was highest in Northwestern China (13.9%) and lowest in Southern China (9.2%), and was higher in rural residents (13.7%) than urban residents (11.1%). The prevalence was higher among current smokers (18.7%) and former smokers (18.7%) than among non-smokers (7.9%).</p>","PeriodicalId":55570,"journal":{"name":"Asia-Pacific Journal of Public Health","volume":" ","pages":"10105395251329194"},"PeriodicalIF":1.4000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Pacific Journal of Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10105395251329194","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic Obstructive Pulmonary Disease (COPD) imposed a heavy disease burden on China. The aim of this study was to identify the prevalence of COPD in adults aged 40 years and older in China through a systematic review and meta-analysis. A web-based search of 11 databases (including PubMed and Web of Science) from January 2014 to September 2024, using specified search/MeSH (Medical Subject Headings) terms and keywords, was conducted. A total of 92 studies (39 320 patients) were included. The combined prevalence of COPD in Chinese adults aged 40 years and older from 2014 to 2024 was 12.1% (11.3%-13.0%). Subgroup analysis showed that the prevalence was higher in males (16.4%, 15.2%-17.6%) than in females (8.4%, 7.5%-9.3%). The lowest prevalence was 4.8% in the age group of 40 to 49 years and 23.7% in the age group of over 70 years. The prevalence was highest in patients with a BMI of less than 18.5 kg/m2 (22.4%) and decreased with increasing BMI. The prevalence was highest in Northwestern China (13.9%) and lowest in Southern China (9.2%), and was higher in rural residents (13.7%) than urban residents (11.1%). The prevalence was higher among current smokers (18.7%) and former smokers (18.7%) than among non-smokers (7.9%).
期刊介绍:
Asia-Pacific Journal of Public Health (APJPH) is a peer-reviewed, bimonthly journal that focuses on health issues in the Asia-Pacific Region. APJPH publishes original articles on public health related issues, including implications for practical applications to professional education and services for public health and primary health care that are of concern and relevance to the Asia-Pacific region.